Quad by Medvi could support male sexual performance by targeting concerns like arousal, erection quality, and low sexual drive. The product may work across several phases of sexual response, including mental arousal, physical readiness, and sustained responsiveness.
This review examines how Quad works, its ingredient profile, benefits, and potential side effects. We also explore the prescribing process, safety considerations, and how the product compares to other compounded medications from competitive brands.
What Is Medvi Quad?
As per the official site, Quad is a clinician-prescribed, compounded male performance medication. It is positioned as a single prescription that combines four medications to support erection quality and sexual performance, namely vardenafil, sildenafil, apomorphine, and tadalafil.
Quad is presented as a combined option that aims to provide faster activation, lasting responsiveness, and support for stimulating sexual desire. Access to the medication follows a structured telehealth process. You can begin by completing a short online intake questionnaire, which is reviewed by a U.S.-licensed physician to determine eligibility for a prescription. If approved, the prescription is issued and shipped in discreet packaging by U.S.-licensed compounding pharmacies.
How Does Medvi Quad Work?
Medvi Quad may function by pairing four prescription compounds that act on different biological pathways involved in sexual response. Instead of relying on a single mechanism, the formulation is intended to support desire, blood flow, and erection stability at the same time.
The medication contains apomorphine, which acts on dopamine receptors in the brain, particularly in areas linked to sexual motivation and arousal signaling. Such stimulation may help improve sexual readiness and mental engagement, thereby supporting sexual performance.
Quad by Medvi also pairs vardenafil and sildenafil, which may work by inhibiting the enzyme phosphodiesterase type 5 (PDE5). When PDE5 is inhibited, blood vessels remain relaxed for longer periods, allowing increased blood flow into the erectile tissue during arousal. Vardenafil is known for its faster onset, while sildenafil is associated with stronger peak effects, which may support quicker response and firmness during sexual activity.
Tadalafil is also included in Quad, whose effects on PDE5 inhibition are described as lasting for an extended window, often up to 36 hours. It does not mean a continuous erection, but rather a prolonged period during which blood flow support remains available when arousal occurs.
Medvi Quad Benefits
Combines Four Active Ingredients
Medvi’s Quad combines four active ingredients, with each ingredient playing a distinct role. For example, Apomorphine works on dopamine pathways in the brain that are linked to libido and sexual desire, while Vardenafil supports quicker blood flow response and is associated with faster onset. Sildenafil contributes to firmness and erection strength, while Tadalafil remains active for a longer period to extend responsiveness.
Quad’s approach of combining four ingredients in one formula may help you avoid choosing between fast-acting or long-lasting options or taking separate medications. The sublingual format also removes the need to plan dosing around meals. Such a combination can be a practical benefit if you are looking for consistent timing, broader sexual response, and flexibility over a longer window.
Offers a 36-Hour Response Window
Quad may provide a response window that could last up to 36 hours after a single dose. This extended timeframe is linked to the presence of tadalafil within the sublingual formula. Rather than requiring exact timing before intimacy, the medication remains active in the background, allowing responsiveness to arousal across a much longer period. A longer window allows flexibility across more than one sexual intimacy encounter and reduces the pressure of planning around a narrow effectiveness period. Such a longer response window might be helpful when spontaneity matters or when intimacy may occur at different times over a day or weekend.
Efficacy Unaffected by Food
Medvi Quad uses a sublingual delivery method that claims to keep its effectiveness consistent regardless of food intake. The tablet dissolves under the tongue, which could allow the active compounds like apomorphine, tadalafil, and sildenafil to enter the bloodstream directly. Such a delivery approach avoids the digestive tract and reduces the impact of liver metabolism that often interferes with swallowed pills. As digestion is bypassed, meals do not slow absorption or weaken the response to Quad. The sublingual format could work as intended even after eating, without needing to adjust timing or wait for an empty stomach.
Medvi Quad Side Effects
May Trigger Facial Flushing or Warmth
Medvi Quad may trigger facial flushing or a sensation of warmth, which may feel uncomfortable or noticeable. The effect is primarily linked to the presence of PDE5 inhibitors like vardenafil and sildenafil in the formula, which relax blood vessels to increase blood flow and may lead to temporary vasodilation in areas like the face and neck. This warmth or redness is generally mild and short-lived, but its intensity can vary depending on dose, hydration, and alcohol intake. While usually manageable, it can be more noticeable during early periods of use, which may appear as brief facial redness or warmth after consumption.
Could Lead to Temporary Nasal Congestion
Quad may cause temporary nasal congestion due to the presence of sildenafil and vardenafil in its formulation. These compounds relax blood vessels throughout the body, including those in the nasal passages. As blood vessels in the nose widen, airflow can feel restricted, creating a stuffy or blocked sensation.
The intensity of nasal congestion may vary depending on dose level, hydration status, and sensitivity to vasodilation. Nasal congestion may show up as brief nasal stuffiness or pressure shortly after use.
Might Cause Mild Headaches or Pressure
Medvi Quad influences brain and blood flow activity through compounds like apomorphine, which acts on dopamine receptors and may trigger headaches, especially if you are more sensitive to dopamine-related stimulation. Apomorphine’s action within the central nervous system might cause temporary changes in cerebral blood flow. This can present as a dull headache, heaviness, or pressure around the temples or forehead instead of sharp pain. Headaches or pressure may feel like a lingering tightness, heaviness, or low-level ache in the head. This discomfort could make it harder to relax or focus for a short period.
Pros
- Combines apomorphine, vardenafil, sildenafil, and tadalafil for extended effects.
- The plan includes doctor consultation, 24/7 medical support, and cancel-anytime subscription flexibility.
- USA-made compound medication, professionally formulated by licensed pharmacies for safety and tailored dosing.
- The purchase process is discreet, comprising a 3-minute online evaluation, review by a US-licensed doctor, and discreet medication shipping.
Cons
- Dependence on compounded ingredients may lead to variations in potency, composition, and safety profile.
- A subscription-based pricing model contributes to ongoing purchase costs.
Medvi Quad Alternatives
Rugiet Ready
When comparing the products, Rugiet Ready and Quad by Medvi both focus on supporting erectile function and sexual performance via a telehealth model and compounded medications. However, the products differ in terms of their composition, formulation standards, onset time, and accessibility.
As per its official site, Rugiet Ready offers a sublingual, fast-acting compounded medication that pairs sildenafil, tadalafil, and apomorphine. The formulation comes as a dissolving chewable, which could support erectile function by improving blood flow and influencing arousal signaling from the brain. Quad by Medvi is similarly positioned as a sublingual product but expands the formulation to four ingredients, comprising vardenafil, apomorphine, sildenafil, and tadalafil. The product comes in a sublingual liquid format, described as supporting faster absorption.
Rugiet Ready is described as dissolving under the tongue within five to ten minutes, with effects claimed to begin in about fifteen minutes on average. The emphasis is on bypassing digestion to allow consistent absorption, including after heavier meals. Medvi’s Quad follows a similar sublingual approach but is described as a rapid-absorbing liquid that reaches the bloodstream in approximately 10–15 minutes.
Rugiet Ready and Medvi Quad are both prescription offerings that require an online medical consultation with licensed clinicians in the United States. Rugiet Ready outlines a process involving an intake, physician review within 24–48 hours, and medication delivery within 4-7 days, along with ongoing follow-up access. Quad by Medvi describes a shorter intake process, doctor review within 24 hours, instant prescription if approved, and free rush shipping, with continued medical support included.
Pricing information is presented differently between the two products. Rugiet Ready references subscription-based pricing options and promotional discounts, like a one-month supply free with a 3-month plan. However, it does not provide a specific monthly medication cost upfront. Medvi lists a retail subscription price of $199 per month and explains this in relation to the cost of obtaining the four medications separately.
Rugiet Ready and Quad by Medvi share similarities in sublingual delivery, telehealth access, and combined medication approaches. However, the products differ in the number of active medications, formulation structure, and pricing transparency.
Ro Sparks
Ro Sparks and Medvi Quad both offer compounded ED medications to support sexual performance and erection quality via a structured online telehealth model. However, there are differences in terms of the number of ingredients, pricing structure, format of medications, and accessibility.
Sparks by Ro is a sublingual compounded medication that pairs two active ingredients, namely sildenafil and tadalafil. The formulation is designed to dissolve under the tongue over several minutes, with absorption occurring directly into the bloodstream and an average onset noted around 15 minutes. The intake process to obtain Sparks involves completing a detailed online medical questionnaire, typically taking about 20 minutes, followed by review from a licensed provider and medication shipment, typically within 4-7 days. Medvi’s Quad combines four active compounds in one formulation, namely sildenafil, apomorphine, tadalafil, and vardenafil. Quad is delivered as a rapid-absorb liquid placed under the tongue, with absorption also described as bypassing digestion and reaching the bloodstream within 10–15 minutes. The onboarding process for Quad emphasizes a shorter intake questionnaire of about three minutes, clinician review within 24 hours, and expedited, discreet delivery of medications.
In terms of pricing, there are some differences between the products. Ro Sparks is priced on a per-dose subscription model, listed at $12 per dose with monthly or quarterly plans offering between four and ten doses. Quad by Medvi offers a bundled monthly prescription starting at a retail price of $199 per month.
Ro Sparks reflects a two-ingredient compounded option within a larger telehealth system that also supports traditional prescriptions and broader health categories. Meanwhile, Quad by Medvi reflects a four-ingredient compounded prescription offered as a consolidated formula and accessed through a more streamlined intake process.
Frequently Asked Questions
No. Quad contains apomorphine, vardenafil, and sildenafil, which may lower blood pressure. It is contraindicated with nitrates due to the risk of severe hypotension and cardiac events. Before using the product, a physician assessment is required, especially in cases of cardiovascular conditions like hypertension or coronary artery disease.
Physical dependency risks with Quad are not documented. Its active ingredients, like sildenafil, tadalafil, vardenafil, and apomorphine, are not associated with physiological addiction or withdrawal. However, use should follow medical guidance to avoid overuse.
No. Quad is not intended to directly increase libido. It contains apomorphine that may influence arousal pathways, but this effect is variable and not positioned as a consistent libido enhancement with the product.
Conclusion
Quad by Medvi focuses on rapid absorption and extended duration through sublingual delivery. Instead of relying on one active ingredient, the formulation combines multiple actives, placing effectiveness and tolerability heavily on absorption efficiency, dosing consistency, and individual suitability.
There are no published clinical trials that evaluate the medication’s four-drug combination, meaning that claims about its performance and safety are not backed by research. As a compounded formulation, Quad is not FDA-approved as a finished product. Its compounded status may introduce potential variability in formulation consistency and quality control between batches.
A combination of multiple PDE5 inhibitors in the product may increase the likelihood of side effects like headache, flushing, fluctuations in blood pressure, and temporary nasal congestion. Ongoing clinician oversight, strict adherence to dosing instructions, and continued monitoring remain necessary when considering using the product.
- About the Author
- Latest Posts
Alisha Matthew has been a practicing nutritionist since 2016. She holds a master’s degree in nutrition from the University of IOWA. She is a staunch believer in improving the human health index by educating people about nutrition and the importance of nutrition in leading a healthy and happy life. Her long-term goal is to keep educating people on general health and keep herself updated with the latest trends in the field of health.